Medtronic Medical Device Infuse Facing Off Label Lawsuit
Medtronic Inc. is facing a medical device lawsuit by a dead patient's family for fatal off label use of Infuse bone graft.
A lawsuit was filed by the family of a woman who suffered fatal respiratory distress when the hospital and doctor used Infuse Bone Graft for her neck surgery. The Infuse Bone Graft is not approved by the FDA for neck surgery. Just weeks before the FDA sent out an alert about how dangerous the off label use Infuse Bone Graft is for neck surgery.
Do You Have a Infuse Bone Graft Lawsuit? »
In another twist of fate: Shareholders sue Medtronic for omissions that falsely inflate the company's stock price.
Shareholders are suing Medtronic because it misinformed investors about the profitability of Infuse Bone Graft because sales depended on applications that were not approved by the Food & Drug Administration (FDA). This important detail was omitted from investors and also wrongly inflated the stock prices.
Is it any surprise that Medtronic is being investigated by the U.S. Department of Justice (DOJ) for questionable business practices?
Medtronic, the second largest medical device maker, is being investigated by the DOJ because a whistleblower claimed that Medtronic sales personnel were in the operating room encouraging the doctor to use the Infuse Bone Graft for the neck surgery. Another accusation is that Medtronic pays doctors generous fees if they write articles, promote, and use Infuse Bone Grant for off label use.
What happened to business and medical ethics?
According to the Wall Street Journal, Medtronic claimed no wrongdoing but agreed to pay $40 million to settle claims made in two whistleblower lawsuits filed by former employees. This led to the investigation of the off-label use of Infuse Bone Graft.
Contact Our Infuse Lawyers Today »
Have you or a loved one faced serious complications or died as the result of Medtronic Infuse Bone Graft medical device? Please contact us to find out if you are eligible for a lawsuit.
